Alerts will be sent to your verified email
Verify EmailGRANULES
Granules India
|
Solara Active Pharma
|
IOL Chem & Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
US DMF Filings
|
37.0 . | 230.0 . | n/a |
Europe DMF Filings
|
5.0 . | n/a | n/a |
Manufacturing Capacity - Metformin
|
2000.0 MTPA | n/a | 11200.0 MTPA |
Manufacturing Capacity - Ibuprofen
|
4800.0 MTPA | 5000.0 MTPA | 12000.0 MTPA |
Total reactor capacity
|
456.5 kL | n/a | n/a |
Pharmaceutical Sector
|
|||
Manufacturing Capacity - Paracetamol
|
34560.0 MTPA | n/a | 3600.0 MTPA |
Number of ANDA's Approved By USFDA
|
64.0 . | n/a | n/a |
Number of ANDA's Filed in USA
|
77.0 . | n/a | n/a |
Number of ANDA's Filed
|
105.0 . | n/a | n/a |
Number of ANDA's Approved
|
85.0 . | n/a | n/a |
R&D as a % of Total Sales
|
1.17 % | n/a | 0.97 % |
Financials
|
|||
5 yr Average ROE
|
18.62 % | 5.09 % | 18.85 % |
5yr average Equity Multiplier
|
1.78 | 1.89 | 1.4 |
5yr Average Asset Turnover Ratio
|
0.84 | 0.58 | 1.09 |
5yr Avg Net Profit Margin
|
12.53 % | 4.11 % | 12.19 % |
Price to Book
|
3.76 | 2.93 | 1.58 |
P/E
|
29.91 | 0.0 | 18.93 |
5yr Avg Cash Conversion Cycle
|
49.48 Days | 138.45 Days | 55.45 Days |
Inventory Days
|
66.04 Days | 90.89 Days | 57.94 Days |
Days Receivable
|
75.78 Days | 129.77 Days | 80.26 Days |
Days Payable
|
105.66 Days | 142.99 Days | 83.28 Days |
5yr Average Interest Coverage Ratio
|
19.25 | 1.64 | 46.53 |
5yr Avg ROCE
|
21.19 % | 8.8 % | 24.63 % |
5yr Avg Operating Profit Margin
|
21.42 % | 16.58 % | 18.65 % |
5 yr average Debt to Equity
|
0.46 | 0.59 | 0.03 |
5yr CAGR Net Profit
|
16.92 % | n/a | -20.73 % |
5yr Average Return on Assets
|
10.57 % | 2.82 % | 13.46 % |
Shareholdings
|
|||
Promoter Holding
|
41.96 % | 30.49 % | 48.19 % |
Share Pledged by Promoters
|
4.03 % | 47.99 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.08 % | -13.62 % | 4.5 % |
Change in Mutual Fund Holding (3 Yrs)
|
5.8 % | -1.9 % | 0.04 % |
Granules India
|
Solara Active Pharma
|
IOL Chem & Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|